U.S. Ambassador, Others Working To Improve Public Health In Nigeria

U.S. Ambassador, Others Working To Improve Public Health In Nigeria

U.S. Ambassador, Others Working To Improve Public Health In Nigeria

U.S. Ambassador Mary Beth Leonard has high­lighted the U.S. Govern­ment’s commitment as well as Varian’s efforts to significantly improving public health outcomes in Nigeria.

 

Delivering remarks at a reception in honor of Varian and attended by members of the Nigeria’s oncology community, Leonard noted that the United States continues to lead the world in med­ical research, innovation and technology, provid­ing solutions to tackle the scourge of cancer through medical devices developed by American companies.

 

Ambassador Leonard commended the Nigeria Sovereign Investment Au­thority-Lagos University Cancer Centre (NLCC) and the Marcelle Ruth Cancer Centre (MRCC) for sharing in the vision of improved cancer care in Nigeria and investing in cancer diagno­sis and treatment facilities equipped with the latest technologies designed and manufactured by Varian.

 

Investment in lifesav­ing cancer diagnostic and treatment machines will improve outcomes for Nigerians,” Ambassador Leonard said. “Addition­ally, this investment at home will reduce instanc­es of medical tourism and increase the capacities for medical service provid­ers.”

 

Varian’s Head of Gov­ernment Affairs and Market Development for Europe, Middle East and Africa, Dr. Kevin Massou­di, explained that Varian has been investing heavily in Africa and that Nigeria is of particular impor­tance given the high can­cer incidence and mortal­ity rates.

 

He noted that technolo­gies such as those Varian manufactures are critical in the fight against cancer and that Nigeria current­ly has significantly low access to these treatment opportunities.

 

Quoting World Health Organization statistics, Massoudi expressed con­cern that cancer incidence and cancer related deaths could almost double in Ni­geria by 2040.

 

“The medical technolo­gy to save lives exists. We need to ensure that those in greatest need obtain ac­cess. Where we live should not determine if we live.

 

We recognize that we must all intensify our ef­forts to defeat this dramat­ically increasing cancer burden.”